Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 in hematologic malignancies.

Blood - 15 Oct 1994

Imamura J, Miyoshi I, Koeffler H P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Hematologic Diseases
Share to Leukemia
Share to Li-Fraumeni Syndrome

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoma

Share to Multiple Myeloma

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 7919360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 in hematologic malignancies.PMID 7919360Read ↗

p53 as a potential target in cancer therapy.Semantic proximity Read ↗

Cancer therapy based on p53.Semantic proximity Read ↗

Recent advances in the understanding of TP53 in haematological malignancies.Semantic proximity Read ↗

The significance of p53 mutations in human cancers.Semantic proximity Read ↗

p53 gene alterations in human hematological malignancies: a review.Semantic proximity Read ↗

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target.Semantic proximity Read ↗

Exploiting the p53 pathway for cancer diagnosis and therapy.Semantic proximity Read ↗

Strategies for therapeutic targeting of the p53 pathway in cancer.Semantic proximity Read ↗

TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment.Semantic proximity Read ↗

Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma.Semantic proximity Read ↗

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.Semantic proximity Read ↗

Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.